Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Hexavalent vaccine
BIOLOGICAL
3 trials
Sponsors
Sanofi Pasteur, a Sanofi Company
, International Centre for Diarrhoeal Disease Research, Bangladesh
, PATH
Conditions
Bacterial Infections
Malaria Vaccines
Neisseria Meningitidis
Polio
Virus Diseases
Phase 2
Infant Malaria Vaccine Schedule Optimization
Recruiting
NCT06879327
PATH
Malaria Vaccines
Start: 2025-05-30
End: 2028-03-22
Target: 1200
Updated: 2025-08-03
Phase 3
Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination
Completed
NCT01839175
Sanofi Pasteur, a Sanofi Company
Bacterial Infections, Neisseria Meningitidis, Virus Diseases
Start: 2013-04-30
End: 2015-02-28
Updated: 2017-09-11
Phase 4
Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)
Not yet recruiting
NCT06748612
International Centre for Diarrhoeal Disease Research, Bangladesh
Polio
Start: 2025-01-28
End: 2027-12-30
Target: 1190
Updated: 2024-12-27
Related Papers
Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers
Vaccine
2018-11-22
12 citations
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
2016-12-09
9 citations